All the patients with C-reactive protein (CRP) ≥ 40 were treated with systemic corticosteroids regardless diagnosis, and the prescribing rate increased with decreasing oxygen saturation in the COPD group (P = 0.004). The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.